Inhibition of mitochondrial calcium-independent phospholipase A 2 (iPLA 2 ) attenuates mitochondrial phospholipid loss and is cardioprotective
Calcium-independent phospholipase A # (iPLA # ) is the predominant phospholipase A # present in myocardium, and its pathophysiological role in acute myocardial infarction has been suggested by the rapid increase in membrane-associated iPLA # activity during myocardial ischaemia and reperfusion (I\R). We therefore examined iPLA # in mitochondrial fractions prepared from Langendorff-perfused adult rabbit hearts. Our studies indicate that iPLA # β is present in rabbit heart mitochondrial inner membranes with no apparent translocation during ischaemia, I\R or preconditioning. Mitochondrion-associated iPLA # was catalytically competent and exhibited 2-, 3-and 2.5-fold increases in measured iPLA # activity following ischaemia, I\R and preconditioning, respectively, when compared with the activity of iPLA # measured in mitochondria from control hearts. Mitochondrial phospholipids are essential for maintaining the ordered structure and function of the organelle. I\R resulted in a rapid overall decrease in phosphatidylcholine and phosphatidylethanolamine glycerophospholipid species, as determined
INTRODUCTION
Phospholipase A # activity has been identified in the heart and implicated as a mediator of ischaemia and reperfusion (I\R) injury [1] [2] [3] [4] . Calcium-independent phospholipase A # (iPLA # ) is the predominant phospholipase A # activity present in myocardium, and a role in acute myocardial infarction has been demonstrated by the rapid increase in membrane-associated iPLA # activity [2] , the nuclear translocation of catalytically competent iPLA # [5] and bromoenol lactone (BEL)-sensitive accelerated nuclear-membrane phospholipid catabolism during myocardial I\R [5] . The myocardium contains two distinct forms of iPLA # , iPLA # β and iPLA # γ [6, 7] . The β-form exists as multiple isoforms of $ 80 kDa which possess different specific activities [6] , whereas the γ-form was determined to have apparent molecular masses of 77 and 63 kDa [7] . Both of these forms are calcium independent and inhibited by BEL [6, 7] . The $ 80 kDa phospholipase (iPLA2β) exists as a multimeric complex of $ 300 kDa, contains eight ankyrin motifs [8] , and is selective for arachidonylated plasmalogen substrates [2, 9] . Plasmalogens are the predominant subclass of the choline and ethanolamine glycerophospholipid pools present in myocardium and possess a vinyl-ether bond between their sn-1 aliphatic group and glycerol backbone [10] . Accelerated plasmalogen catabolism and lysophospholipid accumulation accompany myocardial ischaemia and are probably mediated by the activation of one or more phospholipases [2, 9, 11] .
Abbreviations used : iPLA 2 , calcium-independent phospholipase A 2 ; cPLA 2 , cytosolic phospholipase A 2 ; BEL, bromoenol lactone ; ESI-MS, electrospray ionization MS ; I/R, ischaemia and reperfusion ; AACOCF 3 , arachidonyltrifluoromethyl ketone ; BPE, 2-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-dodecanoyl)-1-hexadecanoyl-sn-glycero-3-phosphoethanolamine ; TTC, 2,3,5-triphenyltetrazolium chloride ; 5-HD, 5-hydroxydecanoic acid ; EF, elongation factor. 1 To whom correspondence should be addressed (e-mail robbieg!scripps.edu).
by electrospray ionization MS, that was partially alleviated by pretreatment of hearts with the iPLA # -specific inhibitor, bromoenol lactone (BEL). Pretreatment of I\R hearts with 10 µM BEL significantly reduced the infarct size almost to that of continuously perfused hearts and was cardioprotective only when administered prior to ischaemia. Cardioprotection by BEL was reversed by the simultaneous perfusion of 100 µM 5-hydroxydecanoate, implicating the mitochondrial K ATP channel in BEL-mediated protection from I\R. Preconditioning also significantly reduced the infarct size in response to I\R but protection was lost by concurrent perfusion of 10 µM arachidonic acid. Taken together, these data strongly implicate mitochondriaassociated iPLA # in the signal transduction of myocardial I\R injury.
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The death of cardiomyocytes has been implicated in both animal models of myocardial ischaemia and human patients with acute myocardial infarction [12] [13] [14] [15] . The induction of cell death by myocardial I\R injury facilitates the loss of a significant proportion of cardiomyocytes and contributes to mortality. Although it has become increasingly clear that myocardial ischaemia and prolonged reperfusion result in the death of myocytes through apoptosis or necrosis, the molecular basis of this process remains to be defined [12, 16] . Several studies have suggested the involvement of phospholipase A # , arachidonic acid release and eicosanoid production in the induction of cell death [17] [18] [19] . The cytosolic phospholipase A # (cPLA # ) has been implicated in arachidonic acid release during tumour necrosis factor α-induced apoptosis [20] [21] [22] and in hydroperoxide-induced cytotoxicity [23] .
Mitochondrial dysfunction from I\R leads to myocardial injury, and the immediate recovery of mitochondrial function is imperative for myocardial contractility and survival [24] . The effects of I\R on mitochondrial function include a transient increase followed by a steady decrease in oxidative phosphorylation, the loss of pyridine nucleotides, impaired respiration through complex I, increased superoxide production, opening of the permeability transition pore, loss of calcium homoeostasis and the release of cytochrome c [24] [25] [26] [27] [28] . Mitochondrial phospholipids are essential for maintaining the ordered structure of the organelle and are necessary for the proper localization and function of key mitochondrial enzymes. The myocardial mito-chondrial membrane phospholipid pool has not been characterized thoroughly. Previous studies have indicated that ischaemia and I\R reduce the amount of total mitochondrial phospholipids [29] . Alterations have been reported in the mitochondrial content of phosphatidylcholine and phosphatidylethanolamine, with the most pronounced changes occurring in the cardiolipin content [29] [30] [31] .
The evaluation of rat myocardial nuclear-membrane phospholipids in response to I\R was recently accomplished by utilizing electrospray ionization MS (ESI-MS) [5] . These studies reported a loss of nuclear choline and ethanolamine glycerophospholipids after I\R that was mediated by iPLA # , which translocated to the nucleus [5] . In the present study, we used ESI-MS to investigate the dynamic alterations in mitochondrial phospholipids that occur during myocardial I\R.
Preconditioning of ischaemic myocardium is a phenomenon in which a series of brief periods of ischaemia followed by reperfusion confers protection to the heart against subsequent extended periods of ischaemia [32] . The mitochondrial K ATP channel has been proposed to mediate the effects of ischaemic preconditioning [33] . The pharmacological opening of the mitochondrial K ATP channel through the use of diazoxide before ischaemia has been shown to significantly reduce the extent of the resulting infarction [34, 35] . Additionally, phospholipase A # activity and the release of arachidonic acid have been implicated as antagonists of mitochondrial K ATP channel activity [36] [37] [38] . Accordingly, we used the mitochondrial K ATP channel antagonist, 5-hydroxydecanoic acid (5-HD), in studies of BEL-sensitive cardioprotection during I\R. The involvement of iPLA # and arachidonic acid release in preconditioning through opening of the mitochondrial K ATP channel was also examined.
Since membrane-associated iPLA # activity increases in ischaemic hearts [2] we investigated the role of iPLA # in the signal transduction of myocardial I\R injury. We report that catalytically competent iPLA # is localized to the outer face of the inner mitochondrial membrane and contributes to a decrease in mitochondrial phospholipid content during I\R. Additionally, our results indicate that inhibition of iPLA # by BEL is cardioprotective, as reflected by a reduction in infarct size after global I\R. We concluded that iPLA # activity is detrimental to the heart through the release of arachidonic acid and closure of the mitochondrial K ATP channels. Therefore, the specific inhibition of myocardial iPLA # may be a point of intervention to prevent post-ischaemic myocardial tissue loss.
MATERIALS AND METHODS

Materials
New Zealand White rabbits ( 2.5 kg, male) were obtained from Western Oregon Animal (Philomath, OR, U.S.A.). Anti-iPLA # and anti-Hsp60 were purchased from Cayman Chemicals (Ann Arbor, MI, U.S.A.) and Stressgen (Victoria, BC, Canada), respectively. Anti-EF-Tu\Ts antibody (where EF corresponds to elongation factor ; raised against the complex of EF-Tu-EF-Ts, recognizes EF-Tu in inner membrane and matrix and EF-Ts in matrix ; we used detection of EF-Ts as a marker of matrix) and anti-Rieske FeS antibody (raised against the Rieske iron-sulphur protein of the inner mitochondrial membrane) were gifts from Dr Linda Spremulli (University of North Carolina, Chapel Hill, NC, U.S.A.) and Dr Akemi Matsuno-Yagi (The Scripps Research Institute, La Jolla, CA, U.S.A.), respectively. Goat anti-rabbit IgG and goat anti-mouse IgG antibodies (both alkaline phosphatase-conjugated) were purchased from Caltag Laboratories (Burlingame, CA, U.S.A.). Electrophoresis-grade reagents for PAGE and prepackaged gels were purchased from Sigma (St Louis, MO, U.S.A.) and Invitrogen (Carlsbad, CA, U.S.A.), respectively. BEL and arachidonyltrifluoromethyl ketone (AACOCF $ ) were purchased from Calbiochem (La Jolla, CA, U.S.A.). The iPLA # substrate, 2-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-dodecanoyl)-1-hexadecanoyl-snglycero-3-phosphoethanolamine (BPE), was purchased from Molecular Probes (Eugene, OR, U.S.A.). Silica gel 60 TLC plates were obtained from Whatman (Clifton, NJ, U.S.A.). Dimyristoylphosphatidylcholine and dimyristoylphosphatidylethanolamine were purchased from Avanti Polar Lipids (Alabaster, AL, U.S.A.) and arachidonic acid was purchased from Sigma. 2,3,5-Triphenyltetrazolium chloride (TTC) and 5-HD were purchased from Sigma. All other reagents were of the highest grade available and were purchased from Sigma or Fisher (Pittsburgh, PA, U.S.A.).
Langendorff perfusion of rabbit hearts subjected to myocardial I/R and infarct size studies
Rabbits were utilized for the preparation of Langendorff-perfused hearts as described previously [39] . The experiments were performed in accordance with the National Institutes of Health's Guide for the Care and Use of Laboratory Animals and all experimental procedures were approved by the Scripps Research Institute Animal Care and Use Committee. In brief, rabbits were anaesthetized with ketamine and xylazine (45 and 4 mg\kg, respectively ; subcutaneously) followed by heparin (1000 units ; intravenously), before being killed with pentobarbital sodium (100 mg ; intravenously). Hearts were removed rapidly and perfused in a retrograde fashion through the aorta with a modified Krebs-Ringer buffer (118.5 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl # , 1.18 mM KH # PO % , 1.18 mM MgSO % , 25 mM NaHCO $ and 11.1 mM glucose ; equilibrated with 95 % O # \5 % CO # , pH 7.35) at 37 mC. Following an initial equilibration time of 15 min, hearts were subjected to a non-infarcted control perfusion for 30, 90 or 120 min, 30 min of global zero-flow ischaemia, or 30 or 45 min of global zero-flow ischaemia followed by reperfusion for 120 min. In selected experiments, either 10 µM BEL or 10 µM AACOCF $ was included in the perfusion buffer for 15 min following the initial equilibration period and before global ischaemia. Arachidonic acid (10 µM) or 100 µM 5-HD was perfused either during preconditioning or simultaneously with BEL treatment, respectively. Ischaemic preconditioning was induced by three cycles of 5 min of global ischaemia and 5 min of reperfusion immediately preceding the regular I\R protocols.
After 120 min of reperfusion, infarct size was determined as described previously [40, 41] . In brief, the heart was frozen, cut into rings of 2 mm thickness, and incubated in 1 % TTC in PBS (pH 7.0) at 37 mC for 20 min. Following the TTC reaction, tissue slices were fixed with 3.7 % formaldehyde in PBS for 20 min and washed twice with PBS. Heart slices were scanned, and the images converted into TIFF files and analysed in Adobe PhotoShop 5.5. The images were manipulated digitally in an identical manner to obtain histograms containing only red and white, corresponding to non-infarcted and infarcted regions, respectively. The infarct size was calculated as ' white ' counts divided by the sum of ' red ' plus ' white ' counts.
Preparation of myocardial mitochondria and cytosol
Mitochondria were prepared as described previously [42] and all procedures were performed at 4 mC. Ventricles were minced in 20 ml of MSE buffer (225 mM mannitol, 75 mM sucrose, 1 mM Mitochondrial phospholipase in ischaemia EGTA and 20 mM Hepes\KOH, pH 7.4) and homogenized further by a Polytron homogenizer for 5 s at maximum power. The homogenate was centrifuged for 10 min at 600 g max , nuclear and cytoskeletal fractions were discarded, and the centrifugation was repeated. The supernatant was centrifuged for 10 min at 10 000 g max to pellet mitochondria. The supernatant (crude cytosol) was centrifuged for a further 30 min at 100 000 g max to obtain cytosol. The mitochondrial pellet was washed twice in 10 ml of MSE buffer and the final pellet was subjected to a hybrid Percoll\metrizamide discontinuous gradient purification consisting of 6 % Percoll and 17 % and 35 % metrizamide, prepared in 250 mM sucrose [42] . The pellet was washed twice in MSE buffer and resuspended in MSE buffer for iPLA # assays or Westernblot analysis. For ESI-MS analyses, mitochondria were resuspended in PBS and extracted immediately (see below). For experiments involving digitonin and limited proteinase K digestion, mitochondria were incubated with 50 µg\ml proteinase K, treated with 0.1 % digitonin, or treated with proteinase K and digitonin in the presence or absence of 1 mM PMSF for 30 min at 4 mC.
Suborganellar fractionation of mitochondria
Isolated and purified mitochondria were fractionated by a modification of Comte and Gautheron [43] . In brief, purified mitochondria were subjected to hypotonic swelling by incubation in 10 mM KH # PO % , pH 7.4, for 20 min at 4 mC. The mitochondria were centrifuged for 15 min at 10 000 g max to pellet mitoplasts (inner membrane and matrix). The supernatant consisting of the outer membrane and contents of the intermembrane space was centrifuged for 30 min at 100 000 g max to separate the outer membrane (pellet) and intermembrane-space contents (supernatant). The mitoplast pellet was resuspended in MC buffer (300 mM sucrose, 1 mM EGTA and 20 mM Mops, pH 7.4) and sonicated on ice for 5 cycles of 20 s bursts with 30 s rest intervals at 8-10 W. The sonicated mitoplasts were centrifuged for 10 min at 10 000 g max to clear any remaining intact mitoplasts and the supernatant was centrifuged for 30 min at 100 000 g max to separate the inner membrane (pellet) and matrix (supernatant). For experiments involving the alkali treatment of inner membranes, inner membranes were incubated with 0.1 mM Na # CO $ , pH 11.5, for 30 min at 4 mC followed by centrifugation at 100 000 g max for 30 min.
Western-blot analysis of iPLA 2
Mitochondrial proteins were quantified by the Coomassie Blue binding assay (Pierce Chemical Co.) with BSA standards, adjusted subsequently to equal protein concentrations and solubilized in SDS sample buffer prior to Western-blot analysis. Anti-iPLA # antibody was used at a 1 : 1000 dilution followed by alkaline phosphatase-conjugated secondary antibody (goat anti-rabbit IgG, 1 : 7000 dilution). Anti-Hsp60, anti-Rieske FeS and anti-EF-Tu\Ts were used at 1 : 1000 dilutions followed by alkaline phosphatase-conjugated secondary antibodies. For anti-Hsp60 and anti-Rieske FeS, goat anti-rabbit IgG was used at a dilution of 1 : 7000 ; for anti-EF-Tu\Ts, goat anti-mouse IgG was used (1 : 7000 dilution).
iPLA 2 
assay and ESI-MS of mitochondrial membrane phospholipids
The iPLA # activity in 50 µg of mitochondria was measured in itro as described previously by measuring the release
from BPE [5, 44] . TLC plates were photographed under UV light using Polaroid film and quantified by densitometry. Fluorescence in a single band was quantified as a percentage of total fluorescence observed for each reaction (an entire lane of the TLC plate) to correct for any variations in sample application. This value was then converted into pmol\min per mg of mitochondrial protein. BEL was included at a final concentration of 10 µM in selected assays to confirm iPLA # activity. Lipids from isolated mitochondria were extracted by the method of Bligh and Dyer [45] in the presence of internal standards.
Chloroform extracts from 5 mg of mitochondrial protein were used for analysis of individual phospholipid molecular species utilizing a Hewlett Packard 1100 MSD single-quadrupole mass spectrometer as described previously [5, 46] . Individual molecular species were quantified by comparisons of the individual ion peak intensities with that of either dimyristoylphosphatidylcholine or dimyristoylphosphatidylethanolamine after correction for "$C isotope effects. The assignment of individual molecular species was as described previously [5] .
Statistical analyses
Data are presented as meanspS.E.M. For comparisons between two groups, ANOVA was performed. A P value of less than 0.05 was considered significant.
RESULTS
Submitochondrial localization of iPLA 2 during myocardial I/R
We investigated iPLA # in mitochondria from control, ischaemic, I\R and preconditioned rabbit hearts. Western-blot analyses of mitochondria demonstrated that iPLA # β was present in mitochondria from control perfused hearts with no apparent translocation to, or from, the mitochondria in response to ischaemia, I\R or preconditioning ( Figure 1A) . A small amount of iPLA # β was detected in cytosolic fractions from ischaemic, I\R and preconditioned hearts and may have increased following I\R and preconditioning ( Figure 1A ). This is possibly due to mitochondrial leakage during processing of the mitochondria ; however, iPLA # activity has been demonstrated in the cytosolic compartment [5, 8, 47] . Additionally, another dominant band of lower molecular mass is clearly detected in the cytosolic fraction and may represent a different isoform of iPLA # . In contrast with iPLA # , neither cPLA # nor secreted PLA # was detected in mitochondrial fractions from any hearts (results not shown). The mitochondrial localization of iPLA # was confirmed visually by immunohistochemical analysis in rat neonatal cardiac myocytes by the co-localization of iPLA # with Mitotracker Red (results not shown).
The subcellular localization of iPLA # to the mitochondria was determined further to be localized specifically to the inner mitochondrial membrane. Metrizamide-purified mitochondria from control perfused rabbit hearts were osmotically shocked to yield mitoplasts (inner membrane and matrix) and the combination of the outer membrane and intermembrane space. Western-blot analysis detected the absence of iPLA # in the outer membranes and intermembrane space ( Figure 1B ). In contrast, iPLA # was abundant in mitoplasts ( Figure 1B ). Further fractionation of mitoplasts into inner membranes and matrix indicated that iPLA # was restricted to the inner membranes ( Figure  1B) .
The isolation and purification of the submitochondrial fractions was demonstrated by Western-blot analyses of several mitochondrial marker proteins ( Figure 1C ). The purity of the mitoplast (inner membranejmatrix) was confirmed by the
Figure 1 Submitochondrial localization of iPLA 2 prepared from isolated perfused rabbit hearts
(A) Mitochondria and cytosolic fractions were prepared and subjected to Western-blot analysis as described in the Materials and methods section. PC, preconditioning. (B) Submitochondrial fractions were prepared and subjected to Western-blot analysis as described in the Materials and methods section. The iPLA 2 was detected with anti-iPLA 2 antibody and visualized by antirabbit antibody conjugated to alkaline phosphatase, as described in the Materials and methods section. (C) Submitochondrial marker analysis of mitochondrial fractions prepared from isolated an perfused rabbit hearts. Outer membrane (OM), intermembrane space (IMS), inner membrane (IM) and matrix (MTX) were prepared from isolated perfused adult rabbit hearts that were control perfused as described in the Materials and methods section. Submitochondrial proteins were subjected to SDS/PAGE and Western-blot analysis as described in the Materials and methods section.
presence of Hsp60 in both the inner membrane and matrix fractions ( Figure 1C ). Hsp60 is predominantly a matrix protein, but does associate with the inner mitochondrial membrane. To demonstrate the purity of the inner membrane and matrix submitochondrial fractions further, the Rieske FeS protein, an
Figure 2 Western-blot analysis of mitochondria isolated from control perfused rabbit heart
Mitochondria were prepared from control perfused rabbits hearts and either not treated (control), treated with 50 µg/ml proteinase K, 0.1 % digitonin or both in the presence or absence of PMSF for 30 min at 4 mC (A). Inner mitochondrial (IM) membranes were prepared as described in the Materials and methods section and incubated with an equal volume of 0.1 M Na 2 CO 3 , pH 11.5, for 30 min at 4 mC (B). Mitochondria and inner membranes were subjected to Western-blot analysis with anti-iPLA 2 and visualized by alkaline phosphatase-conjugated secondary antibody.
inner mitochondrial membrane protein, was demonstrated to be enriched only in the inner membrane fraction ( Figure 1C) . Additionally, the soluble subunit of the mitochondrial elongation factor (EF-Ts), which is specifically a mitochondrial matrix protein, was enriched in the matrix fraction ( Figure 1C ).
Catalytically competent iPLA 2 is localized to the outer face of the inner mitochondrial membrane
Confirmation of the localization of iPLA # to the inner mitochondrial membrane was obtained in experiments utilizing digitonin and limited proteinase K digestion. Western-blot analysis of mitochondria isolated from control perfused rabbit heart treated with 50 µg\ml proteinase K did not result in the proteolysis of iPLA # (Figure 2A ), confirming that iPLA # was not exposed on the outer mitochondrial membrane and verifying that the isolated mitochondria had intact outer membranes. Permeabilization of mitochondria with 0.1 % digitonin followed by proteinase K digestion led to proteolysis of iPLA # (Figure 2A ), indicating that iPLA # was exposed to the intermembrane space. Since iPLA # localized with mitoplasts, and specifically with the inner mitochondrial membrane, we conclude that iPLA # is located on the outer face of the inner mitochondrial membrane. This assessment was confirmed by treatment of mitochondrial inner membranes with 0.1 M sodium carbonate, pH 11.5. Alkali treatment of mitochondrial inner membranes completely dissociated iPLA # from the inner membranes ( Figure 2B ), revealing that iPLA # is a peripheral membrane protein and not integrated into the lipid bilayer.
In addition to the submitochondrial localization of iPLA # , mitochondrial iPLA # was found to be catalytically competent (Table 1) . Myocardial ischaemia and I\R resulted in 2-and 3-fold increases in measured mitochondrial iPLA # activity, respectively. Additionally, preconditioning did not significantly reduce mitochondrially associated iPLA # activity (Table 1 ). Mitochondrial iPLA # activity was calcium-independent and was inhibited totally by the addition of the iPLA # inhibitor, BEL, to the assays (Table 1 ). The difficulties inherent in assaying endogenous membrane-associated phospholipase activity with exogenous labelled phospholipids should be appreciated. Problems such as the appropriate substrate access, interfacial kinetics and surface dilution complicate the interpretation of the results. Therefore, the specific activity of iPLA # measured in intact mitochondria may not be an accurate representation of the
Table 2 Alterations in choline glycerophospholipid mass during I/R conditions in rabbit myocardial mitochondria
Mitochondria were prepared from isolated and perfused rabbit hearts as described in the Materials and methods section. Mitochondrial membrane phospholipids were extracted by the method of Bligh and Dyer [45] and analysed directly by positive-ion ESI-MS. The results are expressed in pmol/µg of mitochondrial protein and represent meanspS.E.M. from three separate experiments. D (diacyl) and P (plasmenyl) indicate phosphatidylcholine and plasmenylcholine molecular species, respectively. Several minor species were also found, which were of insufficient mass ( 0.5 % each) and have not been included. An integer mass was used for all ions and the masses represent the sodiated ions (MjNa + ). endogenous activity of the enzyme during the indicated experimental conditions.
Alterations in the mass of mitochondrial choline glycerophospholipid molecular species induced by myocardial I/R
Analyses of mitochondria isolated from control perfused rabbit hearts by ESI-MS in the positive-ion mode demonstrated the presence of phosphatidylcholine and plasmenylcholine molecular species (Table 2) . Phosphatidylcholine molecular species constituted 42 % of the total choline glycerophospholipid mass in mitochondria isolated from control perfused rabbit hearts (Table  2) . Plasmalogen molecular species were in the majority, constituting 58 % of the choline glycerophospholipids ( Table 2 ). The predominant fatty acid in the sn-1 position of choline glycerophospholipids was palmitic acid, with stearic and oleic acids comprising the remaining fatty acids detected. The fatty acids in the sn-2 position were equally distributed between oleic, linoleic and arachidonic acids ( Table 2) .
Comparisons of positive-ion ESI mass spectra of mitochondrial phospholipids from hearts subjected to control and I\R conditions demonstrated that I\R induced the hydrolysis of 47 % of the total choline glycerophospholipid molecular species (Figure 3 ). Only two choline glycerophospholipid molecular species identified by ESI-MS, 16 : 0-18 : 2 and 18 : 0-18 : 1 phosphatidylcholine, did not decrease significantly in mass (Table 2) . Positive-ion ESI mass spectra of mitochondrial phospholipids from preconditioned or BEL-treated hearts followed by I\R revealed significant reductions in the extent of choline glycerophospholipid hydrolysis when compared with choline glycerophospholipid hydrolysis from I\R only ( Figure 3 and Table 2 ). The reduction of hydrolysis was greater for preconditioned hearts than the reduction of hydrolysis for BEL-treated hearts. Preconditioning hearts before I\R resulted in the hydrolysis of 23 % of the total choline glycerophospholipid molecular species, which represented a reduction in hydrolysis of $ 50 % when compared with I\R ( Figure 3 ). BEL treatment of hearts before I\R resulted in the hydrolysis of 38 % of the total choline glycerophospholipid molecular species, a reduction of $ 20 % compared with I\R ( Figure 3) . Preconditioning reduced phospholipid hydrolysis in all choline glycerophospholipid
Figure 3 Total choline and ethanolamine glycerophospholipid mass in rabbit myocardial mitochondria as determined by ESI-MS
Mitochondria were prepared from isolated perfused adult rabbit hearts that were control perfused, subjected to 30 min of global ischaemia followed by 90 min of reperfusion, pretreated with 10 µM BEL for 15 min followed by 30 min of ischaemia and 90 min of reperfusion, or subjected to preconditioning followed by 30 min of ischaemia and 90 min of reperfusion, as described in the Materials and methods section. Mitochondrial membrane phospholipids were extracted and analysed directly by ESI-MS as described in the Materials and methods section. (Table 2) .
Table 3 Alterations in ethanolamine glycerophospholipid mass during I/R conditions in rabbit myocardial mitochondria
Mitochondria were prepared from isolated and perfused rabbit hearts as described in the Materials and methods section. Mitochondrial membrane phospholipids were extracted by the method of Bligh and Dyer [45] and analysed directly by negative-ion ESI-MS. The results are expressed in pmol/µg of mitochondrial protein and represent meanspS.E.M. from three separate experiments. D (diacyl) and P (plasmenyl) indicate phosphatidylethanolamine and plasmenylethanolamine molecular species, respectively. Several minor species were also found that were of insufficient mass ( 0.5 % each) and have not been included. An integer mass was used for all ions and the masses represent the deprotonated ions. 
Myocardial I/R induces alterations in the mass of mitochondrial ethanolamine glycerophospholipid molecular species mediated by iPLA 2
Examination of mitochondrial phospholipids prepared from control perfused rabbit heart by ESI-MS in the negative-ion mode demonstrated the presence of phosphatidylethanolamine and plasmenylethanolamine molecular species, with the former species representing the majority of ethanolamine glycerophospholipids detected. Phosphatidylethanolamine molecular species constituted 53 % of the total ethanolamine glycerophospholipid mass in mitochondria isolated from control perfused rabbit hearts, whereas plasmalogen molecular species constituted 47 % (Table 3) . Ethanolamine glycerophospholipids predominantly contained stearic acid in the sn-1 position and arachidonic acid in the sn-2 position (Table 3) . Plasmenylethanolamine glycerophospholipid molecular subspecies were particularly enriched with arachidonyl residues at the sn-2 position.
Comparisons of negative-ion ESI mass spectra of mitochondrial phospholipids from control and I\R hearts demonstrated that I\R induced the hydrolysis of 58 % of the total ethanolamine glycerophospholipid molecular species (Figure 3 ). Only one ethanolamine glycerophospholipid molecular species identified by ESI-MS, 18 : 0-20 : 4 plasmenylethanolamine, did not decrease significantly in mass (Table 3) . Additional experiments involving preconditioning or BEL treatment in rabbit hearts subjected to I\R demonstrated significant reductions in the extent of ethanolamine glycerophospholipid hydrolysis when compared with that resulting from I\R alone (Table 3 and Figure 3 ). In contrast with the results observed for the choline glycerophospholipid pool, the reduction of hydrolysis was greater for BEL-treated hearts than that observed for preconditioned hearts (Figure 3 ). BEL treatment of hearts prior to I\R resulted in the hydrolysis of 35 % of the total ethanolamine glycerophospholipid molecular species, a reduction of $ 60 % (Figure 3) . Preconditioning of hearts prior to I\R resulted in the hydrolysis of 40 % of the total ethanolamine glycerophospholipid molecular species and represented a reduction in hydrolysis of $ 31 % (Figure 3) . Preconditioning reduced phospholipid hydrolysis in all ethanolamine glycerophospholipids, with the exceptions of
Figure 4 Inhibition of iPLA 2 by BEL reduces infarct size
Isolated perfused rabbit hearts were subjected to either control perfusion or 30 min of global ischaemia followed by 2 h of reperfusion (I/R) in the presence or absence of the selective phospholipase inhibitors BEL or AACOCF 3 (both 10 µM) as described in the Materials and methods section. Infarct size was determined by TTC staining and is reported as a percentage of the risk zone. BEL protected the ischaemic heart only when administered prior to ischaemia. 5-HD (a K ATP channel closer) blocked the cardioprotective effects of BEL treatment. #, Individual experiments ; $, meanpS.E.M. *P 0.05 for comparisons between control and I/R conditions. †P 0.05 for comparisons between I/R and BEL treatment. (Table 3) .
Inhibition of iPLA 2 reduces infarct size and is cardioprotective
Mitochondrial function is essential for myocardial recovery from I\R injury. Since we have identified catalytically competent iPLA # localized to the inner mitochondrial membranes, and since we have demonstrated the BEL-sensitive hydrolysis of mitochondrial membrane phospholipids during I\R, the protective effect of BEL on infarct size was determined. In control perfused hearts or hearts perfused with 10 µM BEL for 15 min, measured infarct sizes were 27.7p5.6 % and 27.5p4.3 %, respectively ( Figure 4 ). It should be appreciated that these experimental conditions were not subjected to ischaemia and the modest baseline infarct sizes obtained in control perfused hearts were due to the Langendorff perfusion model of the isolated, perfused rabbit heart and are within normal acceptable levels for these types of experiment. Isolated and perfused rabbit hearts subjected to 30 min of ischaemia and 90 min of reperfusion (I\R) resulted in an infarct size of 59.2p6.4 % (Figure 4) . Pretreatment of hearts with 10 µM BEL followed by I\R was cardioprotective and reduced infarct size to near continuously perfused (control) levels (34.5p5.1 %), which represented a near complete salvage (Figure 4) . The inhibition of iPLA # by BEL was only cardioprotective when administered prior to the onset of global ischaemia. Experiments in which 10 µM BEL was included only in the reperfusion buffer did not result in a reduction in infarct size (60.3p5.0 %, compared with 59.2p6.4 % for I\R alone ; Figure  4 ). To confirm that the specific inhibition of iPLA # by BEL was cardioprotective, hearts were perfused with the cPLA # inhibitor AACOCF $ . Perfusion of hearts with 10 µM AACOCF $ prior to I\R was not cardioprotective (58.7p5.5 %, compared with 59.2p6.4 % for I\R alone ; Figure 4 ). Control hearts perfused with 10 µM AACOCF $ for 15 min resulted in a measured infarct size that was comparable with those observed in control perfused or control hearts perfused with BEL (Figure 4) .
Inhibition of iPLA 2 reduces infarct size through a K ATP channelsensitive mechanism
The activation of iPLA # results in the production of free fatty acids, namely arachidonic acid, and lysophospholipids. Lysophospholipids have been identified as having the ability to modulate selected ion channels by altering the surrounding lipid bilayer [48] [49] [50] . More importantly, arachidonic acid is a precursor for the production of prostaglandins and leukotrienes. It has been suggested that arachidonic acid and the production of prostaglandins by cyclo-oxygenases 1 and 2 may also directly affect ion channels, specifically the mitochondrial K ATP channel, through currently unknown mechanisms [36] [37] [38] 48, 51] . Since iPLA # is intricately involved in lipid signalling and mediates mitochondrial phospholipid hydrolysis, and since the mitochondrial K ATP channel has been suggested to be modulated by lipid metabolites, we determined the involvement of the mitochondrial K ATP channel in the cardioprotective effects of iPLA # inhibition by BEL in myocardial I\R. Administration of 100 µM 5-HD, a selective mitochondrial K ATP channel closer, simultaneously with 10 µM BEL for 15 min prior to I\R protocols abolished protection, resulting in a measured infarct size of 51.0p3.7 % (compared with 59.2p6.4 for I\R alone ; Figure 4 ). The closing of the mitochondrial K ATP channel has been implicated in myocardial ischaemic injury, and it has been shown that mitochondrial K ATP channel agonists are cardioprotective [52, 53] . This suggests that iPLA # activity is detrimental to the heart and indicates that the products of iPLA # activity may act through a mechanism to close the K ATP channel. We tested this hypothesis by perfusing hearts with arachidonic acid, a product of iPLA # activity on membrane phospholipids. Administration of 10 µM arachidonic acid to control hearts for 2 h did not alter infarct size (23.8p6.0 % ; Figure 5 ). The opening of the mitochondrial K ATP channel has also been implicated in preconditioning [52, 54] . We hypothesized that if preconditioning is cardioprotective through opening of the mitochondrial K ATP channel, and if iPLA # activity is detrimental through closure of the mitochondrial K ATP channel by lipid metabolites, then lipid metabolites should reverse the cardioprotective effects of preconditioning. Hearts that were perfused with 10 µM arachidonic acid for 15 min followed by preconditioning protocols and I\R resulted in the complete
Figure 5 Alleviation of the cardioprotective effects of preconditioning by arachidonic acid
Isolated perfused rabbit hearts were subjected to control perfusion, 30 or 45 min of global ischaemia followed by 2 h of reperfusion (second and sixth columns from the left, respectively), preconditioning (PC) followed by 30 min of ischaemia and 2 h of reperfusion, perfusion with 10 µM arachidonic acid (A.A.) for 2 h, or perfusion with 10 µM arachidonic acid for 15 min followed by preconditioning including 10 µM arachidonic acid followed by 30 min of ischaemia and 2 h of reperfusion. Infarct size was determined by TTC staining and is reported as a percentage of the risk zone. # and $ represent individual experiments and meanspS.E.M., respectively. *P 0.05 for comparisons between control and I/R, preconditioningjarachidonic acid, or 45 min of ischaemia and 2 h of reperfusion. †P 0.05 for comparisons between I/R and preconditioning.
ablation of the cardioprotective effect of preconditioning (75.0p 4.71 % ; Figure 5 ) and produced an infarct size similar to that observed with a 45 min period of ischaemia followed by 2 h of reperfusion (66.0p4.97 % ; Figure 5 ).
DISCUSSION
Although membrane-associated iPLA # activity is increased in ischaemic myocardium, a role for the activation of this phospholipase in myocardial I\R injury has not been defined adequately [2, 9] . The present study now demonstrates for the first time that catalytically competent iPLA # is localized on the outer face of the inner mitochondrial membrane. The localization of iPLA # to the inner mitochondrial membrane is accompanied by accelerated mitochondrial phospholipid catabolism mediated, at least in part, by iPLA # during myocardial I\R and during preconditioning. A component of the decrease in mitochondrial phospholipid content following I\R may also result from a decrease in phospholipid biosynthesis as well as the activity of other phospholipases (e.g. cPLA # and phospholipase D). The work presented herein has utilized ESI-MS to characterize the phospholipid molecular species present in myocardial mitochondria in isolated and perfused rabbit hearts. Analyses indicated abundant choline and ethanolamine glycerophospholipid molecular species consisting of diacyl and plasmalogen molecular subspecies. The primary sn-1 aliphatic chains of choline glycerophospholipids were composed of palmitate residues, whereas oleic, linoleic and arachidonic acids were evenly distributed at the sn-2 position. Ethanolamine glycerophospholipids predominantly contained stearic acid at the sn-1 position whereas the sn-2 position was enriched in arachidonyl residues.
We observed significant decreases in both choline-and ethanolamine-containing glycerophospholipid molecular species from mitochondria isolated from I\R hearts. Our findings are in accordance with a previous study that showed significant decreases in mitochondrial phosphatidylcholine and phosphatidylethanolamine and also cardiolipin from isolated and perfused rat hearts subjected to ischaemia or I\R [29] . Significant decreases in mitochondrial phosphatidylcholine and phosphatidylethanolamine were also observed in ischaemic small intestine, with more prominent decreases resulting from I\R [30] . The content of phosphatidylethanolamine molecular species in liver mitochondria, quantified by reversed-phase HPLC-ESI-MS, has been reported recently [55] . The most abundant phosphatidylethanolamine molecular species in liver mitochondria was 16 : 0-22 : 6 ; however, this phospholipid was not detected in heart mitochondria in the present study. The most abundant ethanolamine glycerophospholipid detected in heart mitochondria consisted of 18 : 0-20 : 4, which was the second most abundant phosphatidylethanolamine molecular species detected in liver mitochondria [55] . Other abundant ethanolamine glycerophospholipid species in heart mitochondria consist of plasmalogen molecular subspecies which are not present in liver mitochondria. The comparisons between heart and liver mitochondrial phospholipids are complicated by the enrichment of plasmalogen molecular subspecies in the myocardium [10] . Therefore, direct comparisons are difficult to establish.
Although membrane-associated iPLA # activity increases during myocardial ischaemia, only one previous study has attempted to localize this phospholipase to a specific subcellular membrane pool. This study reported the nuclear translocation of catalytically competent iPLA # during myocardial I\R in isolated and perfused rat hearts, with concomitant nuclear-membrane catabolism [5] . The present study now demonstrates that catalytically competent iPLA # is localized constitutively to the outer face of the inner mitochondrial membrane. The localization of iPLA # to rabbit heart mitochondria is also accompanied by accelerated mitochondrial-membrane catabolism, which is due in part to iPLA # , based on studies using the iPLA # -specific inhibitor, BEL. It should be appreciated that the concentration of BEL (10 µM) used in these studies is a potent inhibitor of iPLA # activity in itro and has been shown previously to result in the inhibition of phospholipid hydrolysis in isolated perfused rat hearts [5] . These results indicate that iPLA # contributes to the hydrolysis of mitochondrial phosphatidylcholine and phosphatidylethanolamine phospholipid species. Furthermore, we have defined several critical mitochondrial lipid components that are altered during myocardial I\R. We hypothesize that such alterations in mitochondrial membrane phospholipids probably make the membranes more fluid and may be involved in the loss of calcium homoeostasis, permeability transition and release of cytochrome c that occur in mitochondria during apoptosis. In fact, it is well known that ischaemia induces the disruption of the inner mitochondrial membrane and increases its permeability to protons and inhibits the respiratory chain [56] .
Since iPLA # -mediated mitochondrial membrane catabolism has been demonstrated, and since mitochondrial membrane integrity is central to the recovery of ischaemic myocardium, studies were performed to determine the cardioprotective effects of iPLA # inhibition in isolated perfused rabbit hearts. Perfusion of hearts with BEL was cardioprotective when administered prior to the ischaemic episode and significantly reduced the infarct size. In contrast, since the specific cPLA # inhibitor AACOCF $ was not cardioprotective, it is likely that cPLA # is not involved in I\R injury. It should be noted that the effects of BEL on the reduction of phospholipid hydrolysis are not as dramatic as the effects of the inhibitor on infarct size. Therefore, the preservation of mitochondrial membrane phospholipids may not be responsible for the cardioprotective effects observed in this study. The possibility exists that BEL may affect other unidentified signalling pathways independent of the inhibition of iPLA # . The mitochondrial K ATP channel has been implicated in the cardioprotection of hearts during myocardial I\R. It has been reported that arachidonic acid, a product of the enzymic action of iPLA # on phospholipids, directly modulates myocardial K ATP channels by inhibiting K ATP activity [36, 38] . It has also been suggested that iPLA # can modulate K ATP channels in insulinsecreting cell lines, also through arachidonic acid release and the inhibition of K ATP channel activity [37] . Perfusion of isolated rabbit hearts with the K ATP channel blocker 5-HD simultaneously with BEL reversed the cardioprotective effects of BEL. These results suggest that the cardioprotective effect of BEL is due to K ATP channel opening. Therefore, it can be inferred that mitochondrially associated iPLA # activated during myocardial I\R results in the closing of the mitochondrial K ATP channels and precipitates damage to the mitochondria. It should be appreciated that mitochondrial K ATP channels are also located on the inner mitochondrial membrane. The closing of K ATP channels by activated iPLA # is most likely mediated either through the production of free fatty acids, such as arachidonic acid, or through the production of lysophospholipid second messengers. We tested this hypothesis by perfusing hearts with arachidonic acid. Whereas arachidonic acid alone did not induce an infarction, hearts perfused with arachidonic acid prior to preconditioning followed by I\R reversed the cardioprotective effects of preconditioning. Since preconditioning is generally believed to open the mitochondrial K ATP channel, the effect of arachidonic acid on preconditioning can be interpreted to result in the closure of the K ATP channel.
The closing of mitochondrial K ATP channels could impair mitochondrial volume homoeostasis, leading to opening of the mitochondrial permeability transition pore with subsequent induction of cell death. In insulin-secreting HIT cells the addition of low concentrations of lysophospholipids or arachidonic acid reduced K ATP channel activity [48] . Additionally, arachidonic acid could modulate K ATP channel activity through its conversion into prostaglandins by cyclo-oxygenase. Perfusion of rat hearts with prostaglandins I2, E2 and D2 has been shown to activate K ATP channels [38] . Cyclo-oxygenase has also been shown to mediate the cardioprotective effects of the late phase of preconditioning in rabbit hearts [51] . These protective effects of cyclooxygenase and prostaglandin synthesis from arachidonic acid may indicate the dual importance of arachidonic acid in the ischaemic heart. Free arachidonic acid may be detrimental and act to close K ATP channels, whereas arachidonic acid that is converted into prostaglandins may open K ATP channels and be cardioprotective. Whatever the outcome, the unifying theme underlying the role of arachidonic acid in K ATP channel modulation is the initial production of the free fatty acid, through the activity of iPLA # . It should also be appreciated that iPLA # may affect K ATP channels independent of arachidonic acid production through alterations in the lipid composition of the surrounding membrane. The direct action of iPLA # activity on the membrane bilayer has been shown to alter K + channels in the absence of supramicellar concentrations of fatty acids [57] .
In conclusion, the results presented in this study demonstrate the localization of catalytically competent iPLA # to the outer face of the inner membrane of rabbit heart mitochondria. Accelerated mitochondrial membrane phospholipid catabolism mediated in part by iPLA # was observed during I\R of isolated perfused rabbit hearts. Finally, the inhibition of iPLA # by BEL was shown to be cardioprotective through a mechanism that involved the opening of the mitochondrial K ATP channel. These results establish iPLA # and accelerated phospholipid catabolism as key mediators of the pathophysiology of myocardial I\R injury and suggest that iPLA # may represent an important therapeutic target for the amelioration of ischaemic injury.
